125 related articles for article (PubMed ID: 8502484)
1. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes.
Abraham SE; Lobo S; Yaciuk P; Wang HG; Moran E
Oncogene; 1993 Jun; 8(6):1639-47. PubMed ID: 8502484
[TBL] [Abstract][Full Text] [Related]
2. Retinoid-dependent transcription: the RAR/RXR-TBP-EIA/EIA-LA connection.
Meyer M; Sonntag-Buck V; Keaveney M; Stunnenberg HG
Biochem Soc Symp; 1996; 62():97-109. PubMed ID: 8971343
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystallographic studies of eukaryotic transcription initiation factors.
Burley SK
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):483-9. PubMed ID: 8735270
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for repression of class II gene transcription through specific binding of NC2 to TBP-promoter complexes via heterodimeric histone fold domains.
Goppelt A; Stelzer G; Lottspeich F; Meisterernst M
EMBO J; 1996 Jun; 15(12):3105-16. PubMed ID: 8670811
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of transcriptional activation and repression can both involve TFIID.
Manley JL; Um M; Li C; Ashali H
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):517-26. PubMed ID: 8735274
[TBL] [Abstract][Full Text] [Related]
6. Sequence-dependent solution structure and motions of 13 TATA/TBP (TATA-box binding protein) complexes.
Strahs D; Barash D; Qian X; Schlick T
Biopolymers; 2003 Jun; 69(2):216-43. PubMed ID: 12767124
[TBL] [Abstract][Full Text] [Related]
7. The basal transcription factors TBP and TFB from the mesophilic archaeon Methanosarcina mazeii: structure and conformational changes upon interaction with stress-gene promoters.
Thomsen J; De Biase A; Kaczanowski S; Macario AJ; Thomm M; Zielenkiewicz P; MacColl R; Conway de Macario E
J Mol Biol; 2001 Jun; 309(3):589-603. PubMed ID: 11397082
[TBL] [Abstract][Full Text] [Related]
8. p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein.
Martin DW; Subler MA; Muñoz RM; Brown DR; Deb SP; Deb S
Biochem Biophys Res Commun; 1993 Aug; 195(1):428-34. PubMed ID: 8395834
[TBL] [Abstract][Full Text] [Related]
9. Dynamic interplay of TFIIA, TBP and TATA DNA.
Weideman CA; Netter RC; Benjamin LR; McAllister JJ; Schmiedekamp LA; Coleman RA; Pugh BF
J Mol Biol; 1997 Aug; 271(1):61-75. PubMed ID: 9300055
[TBL] [Abstract][Full Text] [Related]
10. The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.
Green M; Panesar NK; Loewenstein PM
Oncogene; 2008 Jul; 27(32):4446-55. PubMed ID: 18408753
[TBL] [Abstract][Full Text] [Related]
11. Mutational and functional analysis of an essential subdomain of the adenovirus E1A N-terminal transcription repression domain.
Loewenstein PM; Arackal S; Green M
Virology; 2006 Aug; 351(2):312-21. PubMed ID: 16678877
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
[TBL] [Abstract][Full Text] [Related]
13. Purification of an active TATA-binding protein-containing factor using a monoclonal antibody that recognizes the human TATA-binding protein.
Chatterjee PK; Pruzan R; Flint SJ
Protein Expr Purif; 1993 Oct; 4(5):445-55. PubMed ID: 7504537
[TBL] [Abstract][Full Text] [Related]
14. The biochemistry of transcription in eukaryotes: a paradigm for multisubunit regulatory complexes.
Tjian R
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):491-9. PubMed ID: 8735271
[TBL] [Abstract][Full Text] [Related]
15. Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.
Wieczorek E; Brand M; Jacq X; Tora L
Nature; 1998 May; 393(6681):187-91. PubMed ID: 9603525
[TBL] [Abstract][Full Text] [Related]
16. Signals for TBP/TATA box recognition.
Bareket-Samish A; Cohen I; Haran TE
J Mol Biol; 2000 Jun; 299(4):965-77. PubMed ID: 10843851
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
[TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes.
Dallas PB; Yaciuk P; Moran E
J Virol; 1997 Feb; 71(2):1726-31. PubMed ID: 8995708
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.
Boyd JM; Loewenstein PM; Tang Qq QQ; Yu L; Green M
J Virol; 2002 Feb; 76(3):1461-74. PubMed ID: 11773419
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1A.
Kraus VB; Inostroza JA; Yeung K; Reinberg D; Nevins JR
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6279-82. PubMed ID: 8022773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
